Rice Hall James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.32M	Buy	1,514,907 +89,819	+6%	+$287K	0.3%	79
2025 Q4	$3.89M	Sell	1,425,088 -26,284	-2%	-$60.8K	0.21%	109
2025 Q3	$3.15M	Sell	1,451,372 -140,203	-9%	-$331K	0.17%	120
2025 Q2	$2.74M	Buy	1,591,575 +22,363	+1%	+$55.6K	0.15%	136
2025 Q1	$5.23M	Sell	1,569,212 -25,320	-2%	-$131K	0.31%	73
2024 Q4	$11.8M	Sell	1,594,532 -84,625	-5%	-$784K	0.65%	46
2024 Q3	$15.8M	Buy	1,679,157 +43,132	+3%	+$409K	0.85%	31
2024 Q2	$13.1M	Sell	1,636,025 -77,800	-5%	-$834K	0.79%	36
2024 Q1	$25.4M	Sell	1,713,825 -37,082	-2%	-$432K	1.45%	17
2023 Q4	$14.2M	Buy	1,750,907 +28,196	+2%	+$148K	0.82%	38
2023 Q3	$7.84M	Sell	1,722,711 -36,048	-2%	-$235K	0.5%	54
2023 Q2	$12.4M	Buy	1,758,759 +28,795	+2%	+$206K	0.7%	45
2023 Q1	$10.6M	Sell	1,729,964 -92,116	-5%	-$636K	0.6%	46
2022 Q4	$11.6M	Buy	1,822,080 +388,024	+27%	+$3.03M	0.67%	42
2022 Q3	$13.7M	Sell	1,434,056 -267,135	-16%	-$3.08M	0.8%	40
2022 Q2	$18.8M	Buy	1,701,191 +616,070	+57%	+$8.07M	0.91%	34
2022 Q1	$18.1M	Buy	1,085,121 +453,337	+72%	+$7.01M	0.72%	43
2021 Q4	$12.1M	Sell	631,784 -230,163	-27%	-$5.07M	0.43%	56
2021 Q3	$21.3M	Sell	861,947 -21,448	-2%	-$505K	0.79%	43
2021 Q2	$23M	Buy	883,395 +177,468	+25%	+$4.61M	0.82%	40
2021 Q1	$22.4M	Sell	705,927 -5,471	-0.8%	-$227K	0.73%	44
2020 Q4	$33M	Sell	711,398 -28,472	-4%	-$1.13M	1.16%	30
2020 Q3	$24.4M	Buy	739,870 +59,933	+9%	+$1.84M	0.98%	33
2020 Q2	$18.7M	Buy	679,937 +227,595	+50%	+$7.48M	0.8%	38
2020 Q1	$13.5M	Buy	+452,342	New	+$12M	0.76%	43